Martynchyk A, Chong G, Khor R, Lee D, et al. Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal
radiotherapy yield high efficacy in treatment-naive follicular lymphoma: Results
from the phase II 'FLUORO' study. Br J Haematol 2026 Apr 8. doi: 10.1111/bjh.70468.
PMID: 41949430
|